Flow Pharma Inc. is a pioneering biotechnology company based in East Palo Alto, CA. They specialize in the engineering and manufacturing of revolutionary medicines, utilizing their unique patented delivery systems and biotechnology. With a focus on immunotherapy innovation, Flow Pharma is dedicated to transforming the treatment and prevention of cancer and viral diseases such as COVID-19 and Ebola. Their product portfolio includes FLOVID-20, a new vaccine for COVID-19, FlowVax Ebola Marburg for long-lasting infection prevention, and FlowVax BreastCA, offering new hope for those with treatment-resistant triple-negative breast cancer.
Driven by cutting-edge research and a mission to provide effective solutions, Flow Pharma is at the forefront of developing powerful immunotherapies. Their medicines are designed to target specific markers on cancer cells and stimulate T-cells for enhanced treatment outcomes. With a commitment to innovation and scalability, Flow Pharma is poised to revolutionize the field of immunotherapy and make a significant impact on global healthcare.
Generated from the website